Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Neoplasms, Plasma Cell 3Multiple Myeloma 3Pneumonia, Pneumococcal 1Ovarian Neoplasms 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Fallopian Tube Neoplasms 1

Interventions

fludarabine phosphate 19Peripheral Blood Stem Cell Transplantation 15Cyclophosphamide 15Whole-Body Irradiation 14Tacrolimus 13Mycophenolic Acid 13Busulfan 12Antilymphocyte Serum 11Rituximab 9Etoposide 7Methotrexate 6Cyclosporine 6Melphalan 5thymoglobulin 4Flow Cytometry 4Carboplatin 4Therapeutics 3Radiotherapy 3Lenalidomide 3In Situ Hybridization, Fluorescence 3Immunohistochemistry 3Gene Expression Profiling 3Filgrastim 3Everolimus 3Amplified Fragment Length Polymorphism Analysis 3Alemtuzumab 3fludarabine 2Vorinostat 2Vincristine 2Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoma, Extranodal NK-T-Cell × Heptavalent Pneumococcal Conjugate Vaccine × Clear all
NCT00569309 2018-03-12

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

Ohio State University Comprehensive Cancer Center

Phase NA Completed
30 enrolled 8 charts
LymphoidPlasma cell

Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡